Survival and predictors of disability in Turkish MS patients

Neurology

Volumn 51, Issue 3, 1998, Pages 765-772

  Kantarci, O ^a   Siva, Aksel ^a,j   Eraksoy, M ^b   Karabudak, R ^c   Sutlas N ^d   Agaoglu J ^e   Turan, F ^f   Ozmenoglu M ^g   Togrul E ^h   Demirkiran, M ⁱ  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d Bakirkoy Mental Hospital   (Turkey)

^e Social Security Hospital   (Turkey)

^f ULUDAG UNIVERSITY   (Turkey)

^g KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^h GULHANE SCHOOL OF MEDICINE   (Turkey)

ⁱ CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^j NONE   (Turkey)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SURVIVAL RATE; TURKEY (REPUBLIC);

EID: 0031750982     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.765     Document Type: Article

References (34)

1. Weinshenker BG, Ebers GC. The natural history of multiple sclerosis. Can J Neurol Sci 1987;14:255-261.
2. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989;112:133-146.
3. Weinshenker BG, Bass B, Rice GPA, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428.
4. Weinshenker BG, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114: 1045-1056.
5. Weinshenker BG, Rice GPA, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain 1991;114:1057-1067.
6. Leibowitz U, Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand 1970;46:53-70.
7. Kurtzke JF, Beebe GW, Nagler B, et al. Studies on the natural history of multiple sclerosis. 8. Early prognostic features of the later course of the illness. J Chronic Dis 1977;30:819-830.
8. Confavreux C, Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980;103:281-300.
9. Poser S, Raun NE, Poser W. Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 1982;66:355-362.
10. Detels R, Clark VA, Valdiviezo NL, Visscher BR, Malmgren RM Dudley JP. Factors associated with a rapid course of multiple sclerosis. Arch Neurol 1982;39:337-341.
11. Thompson AJ, Hutchinson M, Brazil J, et al. A clinical and laboratory study of benign multiple sclerosis. QJM 1986;58: 69-80.
12. Visscher BR, Liu KS, Clark VA, Detels R, Malmgren RM, Dudley JP. Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand 1984;70: 321-328.
13. Clark VA, Detels R, Visscher BR, Valdiviezo NL, Malmgren RM Dudley JP. Factors associated with a malignant or benign course of multiple sclerosis. JAMA 1982;248:856-860.
14. Minderhoud JM, van der Hoeven JH, Prange AJA. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988;78:10-15.
15. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis. Results from an epidemiological survey in North East Scotland. J Neurol Neurosurg Psychiatry 1987;50:523-531.
16. Phadke JG. Clinical aspects of multiple sclerosis in North East Scotland with particular reference to its course and prognosis. Brain 1990;113:1597-1628.
17. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with 25 years of follow-up. Brain 1993;116:117-134.
18. Miller DH, Hornabrook RW, Purdie G. The natural history of multiple sclerosis: a regional study with some longitudinal data. J Neurol Neurosurg Psychiatry 1992;55:341-346.
19. Weinshenker BG. The natural history of multiple sclerosis. Neurol Clin 1995;1:119-146.
20. Kurtzke JF Rating neurological impairment in MS: an Expanded Disability Status Scale (EDSS). Neurology 1983;33: 1444-1452.
21. Kurtzke JF. The disability status scale for MS: apologia pro DSS sua. Neurology 1989;39:291-302.
22. Turkish Multiple Sclerosis Study Group. Proposal for a database to study Turkish multiple sclerosis patients. Presented at the Multiple Sclerosis Symposium; Istanbul, Turkey; May 8, 1994.
23. Turkish Multiple Sclerosis Study Group. Onset symptoms and disability according to the age of onset in MS. J Neuroimmunol 1995;(suppl 1):51. Abstract.
24. Siva A, Kantarci O, Toǧrul E, et al. Prognostic factors in Turkish MS patients. Eur J Neurol 1996;3(suppl 4):23. Abstract.
25. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
26. British and Dutch Multiple Sclerosis Azathioprine Trial Group. Double-masked trial of azathioprine in multiple sclerosis. Lancet 1988;2:179-183.
27. Goodkin DE, Rudick RA, VanderBrug MS, et al. Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 1995;37: 30-40.
28. Cox DR. Regression models and life tables. J R Stat Soc Ser 1972;B34:187-220.
29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
30. Riise T, Gronning M, Aarli JA, Nyland H, Larsen JP, Edland A Prognostic factors for life expectancy in multiple sclerosis analyzed by Cox models. J Clin Epidemiol 1988;41:1031-1036.
31. Rodriguez M, Siva A, Ward J, Stolp-Smith K, O'Brien PC, Kurland LT. Impairment, disability and handicap in multiple sclerosis: a population based study in Olmsted County, Minnesota. Neurology 1994;44:28-33.
32. Poser S, Kurtzke JF, Poser W, Schlaf G. Survival in multiple sclerosis. J Clin Epidemiol 1989;42:159-168.
33. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-1096.
34. Ruse T, Gronning M, Fernandez O, et al. Early prognostic factors for disability in multiple sclerosis; a European multicenter study. Acta Neurol Scand 1992;85:212-218.